Onconetix, Inc. Stock Repurchase Program, Number of Shares Authorized to be Repurchased
Onconetix, Inc. (ONCO) had Stock Repurchase Program, Number of Shares Authorized to be Repurchased of 4.50 million shares as of 2023-12-31, per its 10-K filed 2024-04-11.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased · last filed 2024-04-11
- 2023-12-31: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 4.50M shares.
- 2022-02-23: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 111.11K shares.
| Period end | Stock Repurchase Program, Number of Shares Authorized to be Repurchased |
|---|---|
| 2023-12-31 | 4.50M shares 10-K · filed 2024-04-11 |
| 2022-02-23 | 111.11K shares 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |